Wu Miaomiao, Sun Lidong, Song Tanjing
Deparment of Obstetrics and Gynecology, Shuyang Hospital of Traditional Chinese Medicine, Suqian, China.
Department of Biochemistry and Molecular Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Front Mol Biosci. 2024 Jan 9;10:1261273. doi: 10.3389/fmolb.2023.1261273. eCollection 2023.
Protein ubiquitination plays a pivotal role in protein homeostasis. Ubiquitination may regulate the stability, activity, protein-protein interaction, and localization of a protein. Ubiquitination is subject to regulation by two groups of counteracting enzymes, the E3 ubiquitin ligases and deubiquitinases. Consistently, deubiquitinases are involved in essentially all biological processes. OTUB1, an OTU-family deubiquitinase, is a critical regulator of development, cancer, DNA damage response, and immune response. OTUB1 antagonizes the ubiquitination of a wide-spectrum of proteins through at least two different mechanisms. Besides direct deubiquitination, OTUB1 can also inhibit ubiquitination by non-canonically blocking ubiquitin transfer from certain ubiquitin-conjugases (E2). In this review, we start with a general background of protein ubiquitination and deubiquitination. Next, we introduce the basic characteristics of OTUB1 and then elaborate on the updated biological functions of OTUB1. Afterwards, we discuss potential mechanisms underlying the versatility and specificity of OTUB1 functions. In the end, we discuss the perspective that OTUB1 can be a potential therapeutic target for cancer.
蛋白质泛素化在蛋白质稳态中起着关键作用。泛素化可能调节蛋白质的稳定性、活性、蛋白质-蛋白质相互作用以及定位。泛素化受到两组相互拮抗的酶(E3泛素连接酶和去泛素化酶)的调节。相应地,去泛素化酶几乎参与了所有的生物过程。OTUB1是一种OTU家族的去泛素化酶,是发育、癌症、DNA损伤反应和免疫反应的关键调节因子。OTUB1通过至少两种不同的机制拮抗多种蛋白质的泛素化。除了直接去泛素化外,OTUB1还可以通过非经典地阻断泛素从某些泛素结合酶(E2)的转移来抑制泛素化。在这篇综述中,我们首先介绍蛋白质泛素化和去泛素化的一般背景。接下来,我们介绍OTUB1的基本特征,然后详细阐述OTUB1最新的生物学功能。之后,我们讨论OTUB1功能的多样性和特异性的潜在机制。最后,我们讨论OTUB1可作为癌症潜在治疗靶点的观点。
Nature. 2012-2-22
World J Biol Chem. 2014-5-26
Int J Mol Cell Med. 2024
MedComm (2020). 2024-12-13
Signal Transduct Target Ther. 2023-10-2
Clin Transl Med. 2023-8
Curr Opin Struct Biol. 2023-10
Breast Cancer Res. 2023-6-27
Biochim Biophys Acta Mol Basis Dis. 2023-10
Signal Transduct Target Ther. 2023-4-7